Library Item - Page 565 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Outcome of cilostazol plus aspirin after PCI

Outcome of cilostazol plus aspirin after PCI

Posted by on Mar 21, 2016 in Coronary artery disease | 0 comments

In a nutshell This paper studied the outcome of adding cilostazol (Pletal) to aspirin in patients undergoing percutaneous coronary intervention. The authors found that this reduced rates of heart attack, stroke or revascularization.  Some background Percutaneous coronary intervention is a procedure done to improve blood flow in blocked blood...

Read More

Survival following coronary artery bypass grafting (CABG) in patients with diabetes

Posted by on Mar 21, 2016 in Coronary artery disease | 0 comments

In a nutshell This study investigated long-term survival in patients with type 1 and type 2 diabetes following coronary artery bypass grafting (CABG).  The study concluded that patients with type 1 diabetes had more than double the long-term risk of death after CABG compared with patients without diabetes. The long-term risk of death in patients...

Read More

Can anticoagulant drugs lower the risk of recurring stroke?

Can anticoagulant drugs lower the risk of recurring stroke?

Posted by on Mar 21, 2016 in Stroke | 0 comments

In a nutshell This study investigated whether anticoagulants were effective at preventing second stroke in patients with atrial fibrillation, and when treatment should be started. They concluded that anticoagulants are more effective than antiplatelets, and are most effective when administered between 4 and 14 days after the first stroke. Some...

Read More

Is abatacept more effective with methotrexate or tacrolimus for rheumatoid arthritis?

Is abatacept more effective with methotrexate or tacrolimus for rheumatoid arthritis?

Posted by on Mar 21, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study explored the use of abatacept (ABT, Orencia) with either methotrexate (MTX, Trexall) or tacrolimus (TAC) in rheumatoid arthritis patients who had not responded well to previous drugs. The study concluded that ABT and TAC together showed the best response and could be used together to treat rheumatoid arthritis after other drugs...

Read More

Vitamin D levels and rheumatoid arthritis

Vitamin D levels and rheumatoid arthritis

Posted by on Mar 21, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study explored the relationship between vitamin D levels and rheumatoid arthritis (RA). The study concluded that RA patients frequently had lower vitamin D levels than healthy patients.  Some background RA is a chronic autoimmune disease (when the immune system attacks healthy tissue) that is thought to be caused by both...

Read More

A needle-free treatment for hypoglycemia

A needle-free treatment for hypoglycemia

Posted by on Mar 21, 2016 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness of a nasal glucagon treatment to the standard injectable form.  The study concluded that nasal glucagon was effective in the treatment of hypoglycemia in adults with type 1 diabetes. Some background The current treatment for severe hypoglycemia (dangerously low blood sugar levels) is an...

Read More

The influence of infection on breast cancer recurrence following breast reconstruction

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More

Immunotherapy drug for treating advanced NSCLC

Posted by on Mar 20, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of nivolumab (Opdivo) and docetaxel (Taxotere) for the treatment of advanced squamous-cell non-small-cell lung cancer (NSCLC). The study concluded that nivolumab is more effective and safer than docetaxel for this type of cancer. Some background PD-L1 is a protein that...

Read More